Old Web
English
Sign In
Acemap
>
authorDetail
>
Caroline Voltz
Caroline Voltz
European Medicines Agency
European union
Internal medicine
Adverse effect
Placebo
Medicine
3
Papers
5
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The European Medicines Agency Review of Crizanlizumab for the Prevention of Recurrent Vaso-Occlusive Crises in Patients With Sickle Cell Disease.
2021
Julio Delgado
Caroline Voltz
Milena Stain
Tuomo Lapveteläinen
Susanne Urach
Johanna Lähteenvuo
Karri Penttilä
Christian Gisselbrecht
Harald Enzmann
Francesco Pignatti
Show All
Source
Cite
Save
Citations (0)
The European Medicines Agency Review of Luspatercept for the Treatment of Adult Patients With Transfusion-dependent Anemia Caused by Low-risk Myelodysplastic Syndromes With Ring Sideroblasts or Beta-thalassemia.
2021
Julio Delgado
Caroline Voltz
Milena Stain
Ewa Bałkowiec-Iskra
Brigitte Mueller
Johanna Wernsperger
Iwona Malinowska
Christian Gisselbrecht
Harald Enzmann
Francesco Pignatti
Show All
Source
Cite
Save
Citations (0)
Are products with an orphan designation for oncology indications different from products for other rare indications? A retrospective analysis of European orphan designations granted between 2002-2012
2017
Orphanet Journal of Rare Diseases
Kim Pauwels
Isabelle Huys
Minne Casteels
Kristina Larsson
Caroline Voltz
Karri Penttilä
Thomas Morel
Steven Simoens
Show All
Source
Cite
Save
Citations (5)
1